VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
BX004
Phase 2
Biologic
B
BiomX, Inc.
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Infection
1 trial
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Recruiting
·
B
BiomX, Inc.
·
Phase 2
·
NCT06998043
·
63 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for BX004. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
BX004 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for BX004. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
BiomX, Inc. company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Phase 2
[1]
Company
B
BiomX, Inc.
Related News